Sino Biopharm targets 30 innovative products by 2027
Sino Biopharmaceutical Limited, or Sino Biopharm, expects to have approximately five innovative products approved in China each year, bringing the total of its innovative products to at least 30 by 2027, the company announced at a conference on Thursday, where it released its 2024 annual results. Such continuous innovation efforts demonstrate the company’s commitment to…